BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9491317)

  • 1. Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).
    Wang PW; Iannantuoni K; Davis EM; Espinosa R; Stoffel M; Le Beau MM
    Genes Chromosomes Cancer; 1998 Feb; 21(2):75-81. PubMed ID: 9491317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map.
    Wang PW; Eisenbart JD; Espinosa R; Davis EM; Larson RA; Le Beau MM
    Genomics; 2000 Jul; 67(1):28-39. PubMed ID: 10945467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20.
    Roulston D; Espinosa R; Stoffel M; Bell GI; Le Beau MM
    Blood; 1993 Dec; 82(11):3424-9. PubMed ID: 8241509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate genes on chromosome band 20q12 by physical mapping of translocation breakpoints found in myeloid leukemia cell lines.
    MacGrogan D; Alvarez S; DeBlasio T; Jhanwar SC; Nimer SD
    Oncogene; 2001 Jul; 20(31):4150-60. PubMed ID: 11464281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
    Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
    Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of the minimal commonly deleted segment and identification of candidate tumor-suppressor genes in del(9q) acute myeloid leukemia.
    Sweetser DA; Peniket AJ; Haaland C; Blomberg AA; Zhang Y; Zaidi ST; Dayyani F; Zhao Z; Heerema NA; Boultwood J; Dewald GW; Paietta E; Slovak ML; Willman CL; Wainscoat JS; Bernstein ID; Daly SB
    Genes Chromosomes Cancer; 2005 Nov; 44(3):279-91. PubMed ID: 16015647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).
    Bench AJ; Nacheva EP; Hood TL; Holden JL; French L; Swanton S; Champion KM; Li J; Whittaker P; Stavrides G; Hunt AR; Huntly BJ; Campbell LJ; Bentley DR; Deloukas P; Green AR
    Oncogene; 2000 Aug; 19(34):3902-13. PubMed ID: 10952764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray CGH analyses of chromosomal 20q deletions in patients with hematopoietic malignancies.
    Okada M; Suto Y; Hirai M; Shiseki M; Usami A; Okajima K; Teramura M; Mori N; Motoji T
    Cancer Genet; 2012; 205(1-2):18-24. PubMed ID: 22429594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions of chromosome 5 in malignant myeloid disorders.
    Le Beau MM
    Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
    Zhao N; Stoffel A; Wang PW; Eisenbart JD; Espinosa R; Larson RA; Le Beau MM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6948-53. PubMed ID: 9192672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region.
    Bench AJ; Aldred MA; Humphray SJ; Champion KM; Gilbert JG; Asimakopoulos FA; Deloukas P; Gwilliam R; Bentley DR; Green AR
    Genomics; 1998 May; 49(3):351-62. PubMed ID: 9615219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma.
    De Rienzo A; Balsara BR; Apostolou S; Jhanwar SC; Testa JR
    Oncogene; 2001 Sep; 20(43):6245-9. PubMed ID: 11593434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies.
    Kratz CP; Emerling BM; Donovan S; Laig-Webster M; Taylor BR; Thompson P; Jensen S; Banerjee A; Bonifas J; Makalowski W; Green ED; Le Beau MM; Shannon KM
    Genomics; 2001 Oct; 77(3):171-80. PubMed ID: 11597142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FISH studies identify the i(20q-) anomaly as a der(20)del(20)(q11q13)idic(20)(p11).
    Li T; Xue Y; Wu Y; Pan J
    Genes Chromosomes Cancer; 2006 Jun; 45(6):536-9. PubMed ID: 16506189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of structural abnormalities in the 7q31.3 approximately q34 region in myeloid malignancies.
    González MB; Gutiérrez NC; García JL; Schoenmakers EF; Solé F; Calasanz MJ; San Miguel JF; Hernández JM
    Cancer Genet Cytogenet; 2004 Apr; 150(2):136-43. PubMed ID: 15066321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
    Smoley SA; Fink SR; Paternoster SF; Stockero KJ; Nguyen LP; Nguyen PL; Hanson CA; Dewald GW
    Cancer Genet Cytogenet; 2007 Mar; 173(2):144-9. PubMed ID: 17321330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.